I've noticed that too. Whether or not Obama makes it in again, If they submitted all the proper filings (which it looks like they have) a R/M shouldn't matter on whos in office(I do use that loosly).
Bottom line is, the Pharm company needs to hit the US market, If thats the route they choose to RM and if the product is as good as they say.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.